Publications by authors named "Mark Lipstein"

Claim this Profile
M
Metabolic symbiosis in cancer and its therapeutic implication.
Mark R Lipstein, Ipsita Pal, Susan E Bates, Changchun Deng

Semin Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies.
Changchun Deng, Mark R Lipstein, Luigi Scotto, Xavier O Jirau Serrano, Michael A Mangone

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB.
Changchun Deng, Mark Lipstein, Richard Rodriguez, Xavier O Jirau Serrano, Christine McIntosh

Clin Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma.
Mark Lipstein, Owen O'Connor, Francesca Montanari, Luca Paoluzzi, Danielle Bongero

Clin Lymphoma Myeloma Leuk· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis